|
|
|
|
| LEADER |
00000cam a2200000Ia 4500 |
| 001 |
SCIDIR_on1232262524 |
| 003 |
OCoLC |
| 005 |
20231120010528.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
210122s2021 enk o 001 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|c YDX
|d OPELS
|d OCLCO
|d OCLCF
|d N$T
|d OCLCO
|d K6U
|d OCLCQ
|d GH0
|d OCLCO
|
| 020 |
|
|
|a 9780128149751
|q (electronic bk.)
|
| 020 |
|
|
|a 0128149752
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128149744
|
| 020 |
|
|
|z 0128149744
|
| 035 |
|
|
|a (OCoLC)1232262524
|
| 050 |
|
4 |
|a RC735.I5
|
| 082 |
0 |
4 |
|a 615.8/36
|2 23
|
| 245 |
0 |
0 |
|a Inhaled medicines
|h [electronic resource] :
|b optimizing development through integration of in silico /
|c edited by Stavros Kassinos [and more].
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (xviii, 419 pages) :
|b illustrations
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed February 10, 2021).
|
| 650 |
|
0 |
|a Respiratory therapy.
|
| 650 |
|
0 |
|a Inhalers.
|
| 650 |
|
0 |
|a Intranasal medication.
|
| 650 |
|
2 |
|a Nebulizers and Vaporizers
|0 (DNLM)D009330
|
| 650 |
|
2 |
|a Administration, Intranasal
|0 (DNLM)D000281
|
| 650 |
|
6 |
|a Inhaloth�erapie.
|0 (CaQQLa)201-0050068
|
| 650 |
|
6 |
|a Inhalateurs.
|0 (CaQQLa)201-0321550
|
| 650 |
|
6 |
|a M�edicaments
|x Administration par voie nasale.
|0 (CaQQLa)201-0072642
|
| 650 |
|
7 |
|a Inhalers
|2 fast
|0 (OCoLC)fst00973366
|
| 650 |
|
7 |
|a Intranasal medication
|2 fast
|0 (OCoLC)fst00977778
|
| 650 |
|
7 |
|a Respiratory therapy
|2 fast
|0 (OCoLC)fst01095819
|
| 700 |
1 |
|
|a Kassinos, Stavros.
|
| 776 |
0 |
8 |
|i Print version:
|z 0128149744
|z 9780128149744
|w (OCoLC)1151187041
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128149744
|z Texto completo
|
